newsfilter
← Latest News
ACCESS Newswire·

Helix BioPharma Corp. Extends Period to Exercise Warrants

RICHMOND HILL, ON / ACCESSWIRE / December 14, 2021 / Helix BioPharma Corp. (TSX:HBP)(FSE:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that it